000 01187 a2200337 4500
005 20250511180446.0
264 0 _c19921117
008 199211s 0 0 eng d
022 _a0002-9378
024 7 _a10.1016/s0002-9378(12)80014-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarton, J R
245 0 0 _aMagnesium sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion.
_h[electronic resource]
260 _bAmerican journal of obstetrics and gynecology
_cOct 1992
300 _a931-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCyclic GMP
_xurine
650 0 4 _aFemale
650 0 4 _aGestational Age
650 0 4 _aHumans
650 0 4 _aMagnesium Sulfate
_xtherapeutic use
650 0 4 _aPre-Eclampsia
_xdrug therapy
650 0 4 _aPregnancy
650 0 4 _aRadioimmunoassay
700 1 _aSibai, B M
700 1 _aAhokas, R A
700 1 _aWhybrew, W D
700 1 _aMercer, B M
773 0 _tAmerican journal of obstetrics and gynecology
_gvol. 167
_gno. 4 Pt 1
_gp. 931-4
856 4 0 _uhttps://doi.org/10.1016/s0002-9378(12)80014-7
_zAvailable from publisher's website
999 _c1336037
_d1336037